CLK2
MOLECULAR TARGETCDC like kinase 2
CLK2 (CDC like kinase 2) is targeted by 52 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CLK2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 52 compounds. Use the BiohacksAI search to explore all CLK2 modulators.
About CLK2 as a Drug Target
CLK2 (CDC like kinase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 52 compounds with documented CLK2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CLK2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.